SEC Filing | Yield10 Bioscience, Inc.

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

STATE FARM MUTUAL AUTOMOBILE INSURANCE CO

(Last)

(First)

(Middle)

ONE STATE FARM PLAZA

(Street)

BLOOMINGTON

61710-0001

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/09/2006

3. Issuer Name and Ticker or Trading Symbol
METABOLIX, INC. [ MBLX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series C Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	102,162	⁽¹⁾	D
Series D Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	355,525	⁽¹⁾	D
Series E Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	35,961	⁽¹⁾	D
Series F Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	16,077	⁽¹⁾	D
Series G Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	34,081	⁽¹⁾	D
Series 04 Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	1,002,734	⁽¹⁾	D
Series 04 Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	90,811	⁽¹⁾	D
Series 05 Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	132,431	⁽¹⁾	D
Warrant (right to buy) C-97, C-96R	⁽²⁾	11/04/2008	Common Stock	384,069	0.12	D
Warrant (right to buy) C-119, C-182	⁽²⁾	04/12/2007	Common Stock	154,469	13.21	D
Warrant (right to buy) C-135	⁽²⁾	06/10/2008	Common Stock	47,297	13.21	D

Explanation of Responses:

1. The Issuer's preferred stock will automatically convert into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering. The share amounts reported in Column 3 have been adjusted to reflect the 0.8173-for-one reverse stock split that took place on November 3, 2006.

2. These warrants, which entitle the holder to purchase shares of the Issuer's Common Stock at a set price before the warrant's specified expiration date, are fully vested and exercisable. The share amounts reported in Column 3 have been adjusted to reflect the 0.8173-for-one reverse stock split that took place on November 3, 2006.

	/s/ Michael L. Tipsord, Vice Chairman, Chief Financial Officer & Treasurer, on behalf of State Farm Mutual Automobile Insurance Company	11/09/2006
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.